Searching journal content for articles similar to Seo et al. 22 (11): 2109.

Displaying results 1-10 of 75
For checked items
  1. ...coexpression, potentially fostering tumor progression. On the immunogenic front, HLA-I immunopeptidomics of AsPC-1 cells and DAC13 organoids identify over 11,000 peptides respectively. Althought mutation-derived neoantigens are rare, several peptides are originated from TE-chimeric transcripts, including four...
  2. ...(Bailey et al. 2018) and prostate cancer (Armenia et al. 2018), indicating that the landscape of oncogenic drivers includes many rarely mutated genes.Although previous studies have analyzed subclonal selection in the lung (Jamal-Hanjani et al. 2017) and other tumor types (Loeb et al. 2019), here we...
  3. ...Androgen receptor–mediated assisted loading of the glucocorticoid receptor modulates transcriptional responses in prostate cancer cells Johannes Hiltunen1,3, Laura Helminen1,3, Niina Aaltonen1,3, Kaisa-Mari Launonen1, Hanna Laakso1, Marjo Malinen2, Einari A. Niskanen1, Jorma J. Palvimo1 and Ville...
  4. ...adenocarcinoma (PAAD) was associated with a module related to the TP53 pathway, a key tumor-suppressor pathway that is frequently mutated in cancers. In liver cancer (LIHC), a unique module, M194, was related to xenobiotic metabolism, which is critical for detoxification of foreign substances and may contribute...
  5. ...reveals APA as an underappreciated driver of protumorigenic gene expression in PDAC via the loss of miRNA regulation.Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer with a 5-yr survival rate of 9% (Siegel et al. 2017). Extensive sequencing studies have uncovered recurrently mutated genes (KRAS...
  6. ...therapy to the triple-negative cases that harbor TP53–BCL2L1 interface hotspot mutations.Lastly, we systematically explored the pharmacogenomic landscape of our network-prioritized hotspots. Leveraging drug response profiles of approximately 1000 human cancer cell lines screened with 265 anticancer...
  7. ...relevance of those mutations was further revealed by epi, transcriptome, and protein analyses of the affected signaling pathways. Such structural aberrations were also found in clinical lung adenocarcinoma specimens. Those structural aberrations were unlikely to be reliably detected by conventional short...
  8. ...and Shilatifard 2014; Vallianatos et al. 2018). Genome-wide identification of potential enhancer elements has been facilitated by profiling (1) binding of pioneer transcription factors (TFs), (2) chromatin accessibility, and (3) patterns of histone modifications (for review, see Ren and Yue 2015). Monomethylation...
  9. ...networks operational in Barrett's esophagous and EAC.ResultsIdentification of a network of transcription factors active in EACPreviously we used ATAC-seq to profile the open chromatin landscape of EAC cell lines and identified AP-1 as an important transcription factor family in controlling...
  10. ...’s Hospital, Cambridge CB2 0QQ, United Kingdom The scientific community has avoided using tissue samples from patients that have been exposed to systemic chemotherapy to infer the genomic landscape of a given cancer. Esophageal adenocarcinoma is a heterogeneous, chemoresistant tumor for which the availability...
For checked items

Preprint Server